IR
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Financial Information
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
80,000
60,000
40,000
20,000
0
-20,000
- 2021
- 2022
- 2023
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Current Assets | 20,808 | 20,978 | 16,874 |
| Non-Current Assets | 37,448 | 24,880 | 47,048 |
| Total Assets | 58,256 | 45,857 | 63,922 |
| Current Liabilities | 1,846 | 20,539 | 10,325 |
| Non-Current Liabilities | 17,649 | 2,879 | 13,102 |
| Total Liabilities | 19,496 | 23,419 | 23,427 |
| Capital | 4,866 | 4,866 | 6,801 |
| Retained Earnings | -19,519 | -41,036 | -52,696 |
| Total Equity | 38,761 | 22,439 | 40,495 |
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Sales | 909 | 480 | 0 |
| Operating Profit | -13,011 | -14,911 | -12,198 |
| Profit before Income Tax | -13,071 | -22,865 | -11,611 |
| Net Profit | -13,071 | -22,865 | -11,611 |
| -13,071 | -22,865 | -11,611 | |
| 0 | 0 | 314 |
